ArticleAnnals of general psychiatry2014

What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment.

Susan Ball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.